Trillium Therapeutics Inc. T.TRIL

Healthcare Biotechnology

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.

TSX:TRIL - Post by User

Trillium Therapeutics Inc.

Bullboard Posts

Post by Thereson May 08, 2009 2:59pm

304 Views

Post# 15979057

Blackmont on friday?

14:17:36	V	0.065	+0.005	6,000	19 Desjardins	7 TD Sec	K

	13:56:27	V	0.065	+0.005	15,000	19 Desjardins	7 TD Sec	K

	13:10:32	V	0.065	+0.005	20,000	36 Latimer	7 TD Sec	K

	13:03:40	V	0.065	+0.005	8,000	58 Qtrade	7 TD Sec	K

	13:00:23	V	0.06	-	4,000	7 TD Sec	7 TD Sec	K

	12:45:18	V	0.06	-	33,000	7 TD Sec	7 TD Sec	K

	12:25:39	V	0.065	+0.005	99,000	46 Blackmont	7 TD Sec	K

	12:23:34	V	0.06	-	46,000	7 TD Sec	7 TD Sec	K

	12:20:55	V	0.06	-	10,000	33 Canaccord	7 TD Sec	K

	12:17:09	V	0.06	-	5,000	88 Scotia iTRADE	7 TD Sec	K